1) Packer DL, Mark DB, Robb RA, et al:Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation:The CABANA Randomized Clinical Trial. JAMA 321:1261-1274, 2019
2) Poole JE, Bahnson TD, Monahan KH, et al:Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial. J Am Coll Cardiol 75:3105-3118, 2020
3) Mark DB, Anstrom KJ, Sheng S, et al:Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation:The CABANA Randomized Clinical Trial. JAMA 321:1275-1285, 2019
4) Marrouche NF, Brachmann J, Andresen D, et al:Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med 378:417-427, 2018
5) Fukui A, Tanino T, Yamaguchi T, et al:Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction. J Cardiovasc Electrophysiol 31:682-688, 2020
6) Santangeli P, Di Biase L, Mohanty P, et al:Catheter ablation of atrial fibrillation in octogenarians:safety and outcomes. J Cardiovasc Electrophysiol 23:687-693, 2012
7) Yamaguchi T, Tsuchiya T, Fukui A, et al:Impact of the extent of low-voltage zone on outcomes after voltage-based catheter ablation for persistent atrial fibrillation. J Cardiol 20:427-433, 2018